Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss the project scope and fee and hire the expert who best meets your requirements
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but release the funds only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
USD 80 /hr
Hire Dr. Nisha C.
USD 80 /hr

Health Economist |Health Technology Assessment |Cost Effectiveness Modelling |Budget Impact Analysis |Literature Review

Profile Summary
Subject Matter Expertise
Writing Clinical Trial Documentation, Technical Writing, Newswriting
Research Fact Checking, Gray Literature Search, Systematic Literature Review, Secondary Data Collection
Data & AI Statistical Analysis, Data Visualization
Work Experience

Research Associate

ICON plc

January 2019 - Present

Research Associate

ICON plc

September 2018 - Present

Senior Research Fellow

Council of Scientific and Industrial Reseacrh

April 2012 - September 2017



Academy of Scientific and Innovative Research

January 2012 - January 2018

Masters of Technology (Biotechnology)

Amity University

August 2004 - January 2010

  • Certification details not provided.
Chandran, Nisha and Brahmachari, Samir K(2018). A decade of OSDD for TB: role and outcomes. CURRENT SCIENCE. 115. (10). p. 1858. INDIAN ACAD SCIENCES CV RAMAN AVENUE, SADASHIVANAGAR, PB\# 8005, BANGALORE~…
Chandran, Nisha and Brahmachari, Samir K(2018). Policy as a driver of economic growth: historical evidence from the Indian pharmaceutical industry. CURRENT SCIENCE. 114. (6). p. 1181. INDIAN ACAD SCIENCES CV RAMAN AVENUE, SADASHIVANAGAR, PB\# 8005, BANGALORE~…
Chandran, Nisha and Singh, Manisha G and Thomas, Zakir and Basu, Dipankar and Brahmachari, Samir K(2016). Thrombolytic Treatment for Myocardial Infarction. Economic & Political Weekly. 51. (38). p. 19.
Singh, Manisha G and Chandran, Nisha and Thomas, Zakir(2016). Economic impact of technology interventions—streptokinase delivering affordable healthcare with clot-buster drugs.